SCHEMBL7123428

SCHEMBL7123428

CC(Oc1ccccc1CC1CO1)Oc1ccccc1CC1CO1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.44
GLA P06280 1/20 0.44
ADRA2A P08913 5/20 0.40
ADRA2B P18089 5/20 0.40
ADRA2C P18825 5/20 0.40
HTR1A P08908 4/20 0.40
KCNH2 Q12809 1/20 0.40
SLC6A2 P23975 1/20 0.38
TDP1 Q9NUW8 1/20 0.36
CYP2D6 P10635 1/20 0.35
DRD4 P21917 1/20 0.34
CHRM2 P08172 2/20 0.33
CHRM4 P08173 2/20 0.33
CHRM5 P08912 2/20 0.33
CHRM1 P11229 2/20 0.33
CHRM3 P20309 2/20 0.33
USP2 O75604 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7129037 0.81 ALDH1A1 (0.40) ALDH1A1GLAADRA2AADRA2BADRA2C
SCHEMBL7114249 0.81 CYP2D6 (0.50) ALDH1A1GLAKCNH2SLC6A2CYP2D6
SCHEMBL3372443 0.80 ALDH1A1 (0.46) ALDH1A1GLASLC6A2TDP1CYP2D6
SCHEMBL6305830 0.80 ALDH1A1 (0.46) ALDH1A1GLASLC6A2TDP1CYP2D6
SCHEMBL1312619 0.80 ALDH1A1 (0.46) ALDH1A1GLASLC6A2TDP1CYP2D6
SCHEMBL14199653 0.78 DRD4 (0.51) ALDH1A1GLAHTR1ASLC6A2TDP1
SCHEMBL7123430 0.77 ALDH1A1 (0.47) ALDH1A1GLAADRA2AADRA2BADRA2C
SCHEMBL3910102 0.76 ALDH1A1 (0.38) ALDH1A1GLAADRA2AADRA2BADRA2C
SCHEMBL1129712 0.76 ALDH1A1 (0.64) ALDH1A1GLAADRA2CHTR1ASLC6A2
SCHEMBL7129045 0.76 ALDH1A1 (0.46) ALDH1A1GLATDP1DRD4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6670474-B2 Such as bis-1,2-(2-(2,3-epoxypropyl)phenoxy)ethane; chemical intermediates for formation of epoxy resins PEWS R GARTH (US) 2003-12-30 US claimed
US-20020151731-A1 Novel epoxide derivatives of allylarylphenols PEWS R GARTH (US) 2002-10-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020151731-A1 Novel epoxide derivatives of allylarylphenols EPHX2, CBR3, CYP4X1 ALDH1A1 578/4885GLA 2736/4885ADRA2A 223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.